Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study

Jason A. Roberts(Queensland Health), Claire Roger(Université de Montpellier), María Patricia Hernández-Mitre(The University of Queensland), João Pedro Baptista(Hospitais da Universidade de Coimbra), Monica A. Slavin(Peter MacCallum Cancer Centre), Mohd Basri Mat Nor(International Islamic University Malaysia), Giancarlo Ceccarelli(International Organization for Migration), Markus Zeitlinger(Medical University of Vienna), Jordi Rello(Vall d'Hebron Hospital Universitari), Roger J. M. Brüggemann(Radboud University Nijmegen), Fekade B. Sime(Basil Hetzel Institute), Leonardo Seoane(Ochsner Health System), Jeffrey Lipman(Queensland Health), George Dimοpoulos(National and Kapodistrian University of Athens), Jean‐Yves Lefrant(Université de Montpellier), Mario Venditti(Policlinico Umberto I), Jai N. Darvall(The Royal Melbourne Hospital), Miia Valkonen(University Medical Center Groningen), Wai Tat Wong, Jan J. De Waele(Ghent University Hospital)
Intensive Care Medicine
February 1, 2025
Cited by 33


Related Papers